Literature DB >> 21311641

Primary atypical teratoid/rhabdoid tumor of the spine in an infant.

S Stabouli, M Sdougka, P Tsitspoulos, A Violaki, I Anagnostopoulos, Ch Tsonidis, D Koliouskas.   

Abstract

Atypical teratoid/rhabdoid tumor of the spine is a rare pediatric neoplasm with poor prognosis. We report a case of an atypical teratoid/rhabdoid tumor of the cervical spine in a 2-months-old infant. The patient presented with rapidly progressing tetraparesis and respiratory failure. Magnetic resonance imaging of the spinal cord revealed an intradural, extramedullary mass occupying the spinal canal on the right at the level of C1-C5. Tumor cells were immunohistochemically positive for epithelial membrane antigen, vimentin, cytokeratins, S-100 protein, and CD57/Leu-7 antigen. Despite chemotherapy, the infant presented with progressive neurological deterioration and died 6 months after initial diagnosis. We review the literature on spinal malignant rhabdoid tumor and discuss the pathology, treatment, and outcome of these rare neoplasms.

Entities:  

Keywords:  atypical teratoid tumor; chemotherapy; chromosome 22q; hydrocephalous; rhabdoid tumor; spine

Year:  2010        PMID: 21311641      PMCID: PMC3031327     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  21 in total

1.  Atypical teratoid/rhabdoid tumor of the spinal canal.

Authors:  Serguei Bannykh; Charles Duncan; Eileen Ogle; Joachim M Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Atypical teratoid/rhabdoid tumor arising from the spinal cord--case report and review of the literature.

Authors:  Y Tanizaki; H Oka; S Utsuki; S Shimizu; S Suzuki; K Fujii
Journal:  Clin Neuropathol       Date:  2006 Mar-Apr       Impact factor: 1.368

3.  Spinal atypical teratoid/rhabdoid tumor in a 7-year-old boy.

Authors:  Chii-Shuenn Yang; Yee-Jee Jan; John Wang; Chiung-Chyi Shen; Clayton C C Chen; Ming Chen
Journal:  Neuropathology       Date:  2007-04       Impact factor: 1.906

4.  Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Authors:  Tanya M Tekautz; Christine E Fuller; Susan Blaney; Maryam Fouladi; Alberto Broniscer; Thomas E Merchant; Matthew Krasin; James Dalton; Gregory Hale; Larry E Kun; Dana Wallace; Richard J Gilbertson; Amar Gajjar
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

5.  Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Y C Cheng; J F Lirng; F C Chang; W Y Guo; M M H Teng; C Y Chang; T T Wong; D M T Ho
Journal:  Acta Radiol       Date:  2005-02       Impact factor: 1.990

6.  Atypical teratoid/rhabdoid tumor of the spine.

Authors:  K K Moeller; S Coventry; S Jernigan; T M Moriarty
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

7.  Spinal atypical teratoid/rhabdoid tumor in an infant.

Authors:  T Tamiya; H Nakashima; Y Ono; S Kawada; S Hamazaki; T Furuta; K Matsumoto; T Ohmoto
Journal:  Pediatr Neurosurg       Date:  2000-03       Impact factor: 1.162

8.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Authors:  Joanne M Hilden; Sharon Meerbaum; Peter Burger; Jonathan Finlay; Anna Janss; Bernd W Scheithauer; Andrew W Walter; Lucy B Rorke; Jaclyn A Biegel
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

9.  Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

Authors:  Roger J Packer; Jaclyn A Biegel; Susan Blaney; Jonathan Finlay; J Russell Geyer; Richard Heideman; Joanne Hilden; Anna J Janss; Larry Kun; Gilbert Vezina; Lucy B Rorke; Malcolm Smith
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

10.  MRI of primary spinal atypical teratoid/rhabdoid tumor: a case report and literature review.

Authors:  Hiroshi Kodama; Masayuki Maeda; Hiroshi Imai; Toshio Matsubara; Waro Taki; Kan Takeda
Journal:  J Neurooncol       Date:  2007-03-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.